Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Volt Pharma Associates

VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

Volt Pharma Associates
Engesserstrasse 4B, Freiburg, 79114, Germany
+49 172 6340202
Contact Volt Pharma Associates
Website

 Latest Content from PMHub 

Highlighting Patient Voices, Workforce Well-Being & Health Literacy During & After the Pandemic

Videos and Podcasts | February 11, 2021 | Impetus Digital

We explore the importance of health literacy, patient voices, and workforce wellbeing during COVID-19 with Deborah Collyar (Patient Advocates in Research), Cathryn Gunther (Population Health Alliance) & Catina O'Leary (Health...

Lucid Group: A Community of Purpose

Press Releases | February 11, 2021 | Lucid Group Communications Limited

In this month’s Pharmaceutical Marketing Europe, Lucid Group’s Chief People Officer, Angela Young, discusses the importance of bringing the company’s purpose to life so that its people feel connected to...

Challenges and opportunities during a changing environment for scientific communications – key themes from the ISMPP EU 2021 meeting

Press Releases | February 11, 2021 | Nucleus Global

Nucleus Global’s Ashley Porter shares his thoughts from this year’s ISMPP EU 2021 meeting

Covid-19: how is it affecting prescribing patterns?

White Papers and Resources | February 11, 2021 | Wilmington Healthcare

Oli Hudson, Content Director at Wilmington Healthcare, analyses prescribing data in three key disease areas

A magic milestone: Katherine’s 10-year workiversary

Press Releases | February 9, 2021 | Lucid Group Communications Limited

Katherine Duxbury recently celebrated the momentous and magical milestone of 10 years with Lucid Group – congratulations! Surprise virtual celebrations have been had and, while they were no replacement for...

Leveraging Consumer Insights & Innovative Technologies to Disrupt Healthcare Engagement

Videos and Podcasts | February 4, 2021 | Impetus Digital

Brent Walker, Senior Vice President of Marketing and Analytics, Patient Bond, dives into the world of psychometrics. We explore the roles of AI and machine learning in extracting psychometric insights,...

Wilmington Healthcare launches new platform to map the formulary landscape

Press Releases | February 4, 2021 | Wilmington Healthcare

Healthcare intelligence provider Wilmington Healthcare has launched a new platform that enables pharma companies to develop a clear picture of formulary status across therapy areas and territories in the UK.

Lucid Group – Let’s Start Talking

Press Releases | February 4, 2021 | Lucid Group Communications Limited

We can all help to transform the lives of those we touch by taking the time to talk and listen to one another. The power of conversation, sharing thoughts, worries...

Porterhouse Insights expands its senior team following a year of significant growth.

Press Releases | February 2, 2021 | Porterhouse Medical Group

Porterhouse Medical Group is delighted to welcome David Eatwell, who joins the team at Porterhouse Insights as Director.David, an experienced and innovative pharma insight professional, will bolster the expertise and...

Ashfield Healthcare Communications rebrands as Ashfield Health

Press Releases | February 2, 2021 | Inizio

Ashfield Health, part of UDG Healthcare plc, announces transformational changes including the unveiling of a new Global President, a rebrand, and the launch of two new global agencies.